Combatting Counterfeits In The Biopharma Supply Chain

Source: Life Science Leader

In this executive virtual roundtable (EVR) section, Tim Valko, head of global manufacturing supply chain, Atara Biotherapeutics, shares his thoughts on combatting counterfeits in the biopharmaceutical supply chain, recommending Rx-360 as a resource for the latest information on combatting biopharma counterfeits. Bryan Butman, Ph.D., head of CMC, Precigen, adds to the conversation.